L’Oréal Reports 7.7% Sales Growth to €35.33 Billion as Beauty Business Accelerates
L’Oréal has reported sales of €35.33 billion for the first nine months of 2026, representing growth of 7.7% on a reported basis and 6.9% like for like, supported by strong performances in professional hair care, dermatological beauty and luxury cosmetics.
Galderma Raises 2026 Sales Outlook for Second Consecutive Quarter as Revenues Surge
Swiss dermatology and aesthetics company Galderma has raised its full-year 2026 sales guidance for the second consecutive quarter after reporting strong revenue growth across its therapeutic dermatology, injectable aesthetics and skincare businesses.
Amorepacific Chairman Seo Kyung-bae Transfers KRW4.5 Billion in Shares to Relatives
Amorepacific Group Chairman Seo Kyung-bae has gifted approximately KRW4.5 billion (US$3.2 million) worth of Amorepacific shares to five relatives, according to a regulatory filing in South Korea.
EU Parliament Approves Simplified Rules for Hazardous Substances in Cosmetics
The European Parliament has approved legislation introducing more flexible deadlines for cosmetics manufacturers to withdraw products containing substances classified as carcinogenic, mutagenic or toxic to reproduction (CMR), as part of the EU’s Omnibus VI Chemistry reforms.
BASF Raises Evonik Takeover Bid to More Than €11 Billion as European Chemicals Sector Reshapes
BASF has reportedly increased its takeover offer for German speciality chemicals manufacturer Evonik Industries to more than €11 billion, as consolidation pressures intensify across Europe’s chemicals sector.
P&G Reports 4% Sales Growth in Fiscal Q1 2027 as Beauty Business Strengthens
Procter & Gamble (P&G) has reported a 4% increase in net sales to US$23.3 billion for the first quarter of fiscal 2027, supported by growth across its beauty, grooming and personal care businesses.
UK Government Proposes Tougher Restrictions on High-Risk Cosmetic Procedures
The UK government has announced proposals to restrict high-risk cosmetic procedures to qualified healthcare professionals, introduce tougher penalties for unregulated practitioners and prohibit certain cosmetic treatments for under-18s.
US FDA Approves Phase 2 Clinical Trial of Injectable PDGF for Under-Eye Hollows
The US Food and Drug Administration (FDA) has cleared Lynch Regenerative Medicine’s Investigational New Drug application for a Phase 2 clinical trial evaluating injectable recombinant human platelet-derived growth factor-BB (rhPDGF-BB) as a treatment for under-eye hollowing.
Indonesia Extends Halal Certification Deadlines for Cosmetics and Personal Care to 2028
The Indonesian government has extended certain mandatory halal certification deadlines from October 2026 to 2028, providing additional time for businesses in the cosmetics, personal care, pharmaceutical and food and beverage sectors to meet regulatory requirements.
Kenvue Updates Neutrogena Acne Toner Labelling and Safety Information
Kenvue Brands LLC has updated the product labelling and safety documentation for Neutrogena Oil-Free Acne Stress Control Triple Action Toner, confirming its regulatory classification as an over-the-counter acne treatment.
LATEST NEWS
